Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.8.0.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 16,050 $ 197
Short-term investments 10,000 0
Prepaid expenses 126 0
Total Assets 26,176 197
Current Liabilities:    
Accounts payable and accrued expenses 1,914 506
Accounts payable and accrued expenses - related party 76 1,348
Interest payable 0 57
Accrued interest - related party 0 346
Notes payable - related party 0 2,848
NSC notes payable, short-term 0 1,000
Derivative warrant liability 0 314
Total current liabilities 1,990 6,419
Convertible notes payable, at fair value 0 200
NSC notes payable, long-term (net of debt discount of $0 and $174, respectively) 0 1,826
Total Liabilities 1,990 8,445
Commitments and Contingencies
Stockholders' Equity (Deficit)    
Common Stock ($0.0001 par value), 50,000,000 shares authorized shares; 10,265,174 and 3,257,936 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively 1 1
Common stock issuable, 0 and 83,532 shares as of September 30, 2017 and December 31, 2016, respectively 0 49
Additional paid-in capital 38,603 105
Accumulated deficit (14,418) (8,403)
Total Stockholders' Equity (Deficit) 24,186 (8,248)
Total Liabilities and Stockholders' Equity (Deficit) 26,176 197
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock ($0.0001 par value), 2,000,000 shares authorized Class A Preferred Stock, 250,000 shares issued and outstanding as of September 30, 2017 and December 31, 2016 $ 0 $ 0